ICH M13A published [Design Issues]

posted by ElMaestro  – Denmark, 2024-07-31 16:14 (684 d 17:33 ago) – Posting: # 24114
Views: 8,886

Hi Zuzana,

the ICH document was written in a generic fashion, it does not take into consideration specific cases like yours. This fully justifies a deviation from the guidance. It is for that reason that I think EU regulators would suggest to dose as per SmPC and not as per ICH guidance if you ask for scientific advice. So that is what I would lean towards.

Gut feeling only.

Pass or fail!
ElMaestro

Complete thread:

UA Flag
Activity
 Admin contact
23,654 posts in 4,992 threads, 1,571 registered users;
155 visitors (0 registered, 155 guests [including 25 identified bots]).
Forum time: 09:48 CEST (Europe/Vienna)

Always listen to experts.
They’ll tell you what can’t be done and why.
Then do it.    Robert A. Heinlein

The Bioequivalence and Bioavailability Forum is hosted by
BEBAC Ing. Helmut Schütz
HTML5